Amol Maliwalave

Title: Amol Maliwalave: Innovator in Biologics and CRISPR Technology

Introduction

Amol Maliwalave is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods utilizing CRISPR technology. With a total of six patents to his name, Maliwalave is recognized for his groundbreaking work in protein engineering and therapeutic development.

Latest Patents

Maliwalave's latest patents include a method for obtaining a cell with modified fucosylation pathways, leading to the production of partially fucosylated and non-fucosylated protein products, specifically antibodies. This method employs CRISPR technology to target the Fut8 gene and GMD gene in a cell, which is crucial for developing therapeutics and biomarkers for disease diagnosis and prognosis. Another notable patent involves vectors for cloning and expressing genetic material, including antibody genes. These vectors utilize phage display technology for efficient cloning and screening of potential antibody genes, facilitating the identification of lead molecules against various antigens.

Career Highlights

Maliwalave is currently associated with Zumutor Biologics Inc., where he continues to push the boundaries of biotechnological innovations. His work has not only advanced the understanding of protein fucosylation but has also paved the way for new therapeutic approaches in medicine.

Collaborations

Maliwalave collaborates with talented professionals in his field, including Bhargav Prasad and Divya Unnikrishnan. Their combined expertise contributes to the innovative projects at Zumutor Biologics Inc.

Conclusion

Amol Maliwalave stands out as a key figure in the biotechnology sector, with his innovative patents and contributions to CRISPR technology. His work is instrumental in advancing therapeutic solutions and enhancing our understanding of protein engineering.